In a report released today, Alex Arfaei from BMO Capital maintained a Hold rating on Elanco Animal Health Inc (NYSE: ELAN), with a price target of $33. The company’s shares closed yesterday at $34.58.
According to TipRanks.com, Arfaei is a 4-star analyst with an average return of 8.2% and a 72.2% success rate. Arfaei covers the Healthcare sector, focusing on stocks such as Merck & Company, Eli Lilly & Co, and Bristol Myers.
Elanco Animal Health Inc has an analyst consensus of Hold, with a price target consensus of $33.
See today’s analyst top recommended stocks >>
The company has a one-year high of $36.01 and a one-year low of $32.05. Currently, Elanco Animal Health Inc has an average volume of 13.84M.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Elanco Animal Health, Inc. engages in the innovation, development, manufacture and market products for companion and food animals. It operates through the following categories: Companion Animal Disease Prevention, Companion Animal Therapeutics, Food Animal Future Protein & Health, and Food Animal Ruminants & Swine.
